188 related articles for article (PubMed ID: 27461717)
21. Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis.
Thanee M; Loilome W; Techasen A; Namwat N; Boonmars T; Pairojkul C; Yongvanit P
Asian Pac J Cancer Prev; 2015; 16(7):3043-50. PubMed ID: 25854403
[TBL] [Abstract][Full Text] [Related]
22. Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase.
Kaewmeesri P; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
Asian Pac J Cancer Prev; 2021 Jan; 22(1):219-225. PubMed ID: 33507702
[TBL] [Abstract][Full Text] [Related]
23. Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress.
Chaiprasert T; Armartmuntree N; Techasen A; Sakonsinsiri C; Pinlaor S; Ungarreevittaya P; Khuntikeo N; Namwat N; Thanan R
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31284679
[TBL] [Abstract][Full Text] [Related]
24. Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway.
Tuponchai P; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
J Cancer Res Ther; 2019; 15(1):157-163. PubMed ID: 30880773
[TBL] [Abstract][Full Text] [Related]
25. The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma.
Kaewlert W; Sakonsinsiri C; Namwat N; Sawanyawisuth K; Ungarreevittaya P; Khuntikeo N; Armartmuntree N; Thanan R
Horm Cancer; 2018 Dec; 9(6):408-419. PubMed ID: 30284180
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
[TBL] [Abstract][Full Text] [Related]
27. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient.
Sripa B; Seubwai W; Vaeteewoottacharn K; Sawanyawisuth K; Silsirivanit A; Kaewkong W; Muisuk K; Dana P; Phoomak C; Lert-Itthiporn W; Luvira V; Pairojkul C; Teh BT; Wongkham S; Okada S; Chamgramol Y
Hum Cell; 2020 Jul; 33(3):695-708. PubMed ID: 32207095
[TBL] [Abstract][Full Text] [Related]
28. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
[TBL] [Abstract][Full Text] [Related]
29. Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.
Kotepui KU; Obchoei S; Vaeteewoottacharn K; Okada S; Wongkham S; Sawanyawisuth K
Asian Pac J Cancer Prev; 2022 Feb; 23(2):715-721. PubMed ID: 35225485
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
31. Disruption of endocytic trafficking protein Rab7 impairs invasiveness of cholangiocarcinoma cells.
Suwandittakul N; Reamtong O; Molee P; Maneewatchararangsri S; Sutherat M; Chaisri U; Wongkham S; Adisakwattana P
Cancer Biomark; 2017 Sep; 20(3):255-266. PubMed ID: 28946560
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
33. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L
J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
[TBL] [Abstract][Full Text] [Related]
35. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
Srijiwangsa P; Ponnikorn S; Na-Bangchang K
BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
[TBL] [Abstract][Full Text] [Related]
36. Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis.
Thamrongwaranggoon U; Detarya M; Seubwai W; Saengboonmee C; Hino S; Koga T; Nakao M; Wongkham S
Life Sci; 2022 Aug; 302():120648. PubMed ID: 35598658
[TBL] [Abstract][Full Text] [Related]
37. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma.
Detarya M; Thaenkaew S; Seubwai W; Indramanee S; Phoomak C; Saengboonmee C; Wongkham S; Wongkham C
Life Sci; 2021 Apr; 271():119114. PubMed ID: 33513399
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
39. Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4.
Nie J; Zhang J; Wang L; Lu L; Yuan Q; An F; Zhang S; Jiao Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):183. PubMed ID: 29237483
[TBL] [Abstract][Full Text] [Related]
40. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]